U.S. Mortgage REITs Stock News

If you are wondering whether ServiceNow shares still line up with the price on your screen, this article will walk through what that current market value might really imply. The stock last closed at US$103.87, after recent returns of 12.0% decline over 7 days, 26.7% decline over 30 days, 29.6% decline year to date, 49.2% decline over 1 year, 12.6% over 3 years, and 12.2% decline over 5 years. Recent coverage around ServiceNow has focused on how investors are reassessing high growth software...

Selective Insurance Group recently reported fourth-quarter 2025 results showing revenue of US$1.36 billion and net income of US$155.2 million, alongside board decisions on dividends, share repurchases, and updated corporate bylaws effective January 30, 2026. An interesting aspect of these developments is the combination of stronger quarterly earnings with governance tweaks, including refreshed director eligibility rules and updated CEO/CFO responsibilities, which together highlight how...

If you are wondering whether CoreWeave’s current share price actually reflects its underlying value, you are not alone. This article is built to help you frame that question clearly. CoreWeave recently closed at US$96.79, with returns of 7.5% over 7 days, 20.8% over 30 days and 22.0% year to date, which has raised questions about how much of this is already reflected in the valuation. Recent attention on CoreWeave has centered on its position within AI focused infrastructure and cloud...

Nebius Group (NasdaqGS:NBIS) has agreed to acquire Tavily, a provider of agentic search technology for AI applications. The company is also securing multi billion dollar AI cloud agreements with Microsoft and Meta as part of its infrastructure build out. These developments are aimed at strengthening Nebius's AI cloud platform for enterprise customers. Nebius Group, listed as NasdaqGS:NBIS, focuses on AI centric cloud infrastructure and tooling for enterprise workloads. The Tavily...

WisdomTree (WT) is back in focus after reporting full year 2025 results, showing revenue of US$493.75 million and net income of US$109.13 million, alongside ongoing dividends and fresh momentum in its tokenized funds business. See our latest analysis for WisdomTree. WisdomTree's share price has climbed 18.81% over the past month and 34.85% over the past 90 days, with a 1 year total shareholder return of 66.39% and a 5 year total shareholder return of 196.10%, pointing to strong momentum...

If you are looking at W. R. Berkley and wondering whether the current share price still makes sense for you, it helps to separate sentiment from underlying value. The stock last closed at US$69.25, with returns of 2.2% over 7 days, 1.2% over 30 days, about 0.2% decline year to date, 16.9% over 1 year, 63.1% over 3 years and 158.6% over 5 years, which can shape how the market is thinking about growth and risk. Recent attention on W. R. Berkley has been driven by ongoing investor interest in...

Why Woodward’s latest quarter is drawing fresh attention Woodward (WWD) just posted a quarter that topped expectations, raised its 2026 sales and earnings guidance, and lifted its dividend. This gives investors a fresh, fundamentals based catalyst to reassess the stock. See our latest analysis for Woodward. The stronger earnings, higher 2026 guidance, dividend increase, and ongoing buybacks sit alongside a sharp acceleration in the share price. The 90 day share price return is 45.93% and the...

If you have been wondering whether Travelers Companies is reasonably priced or starting to look expensive, you are not alone. This article is here to focus squarely on what you might be paying for. With the share price at US$292.82 and returns of 1.6% over 7 days, 3.9% over 30 days, 2.7% year to date, 22.8% over 1 year, 68.3% over 3 years and 119.6% over 5 years, many investors are asking how that track record stacks up against the current valuation. Recent coverage has highlighted Travelers...

Why Corteva’s latest earnings matter for shareholders Corteva (CTVA) just released its fourth quarter and full year 2025 results, pairing a quarterly net loss with higher full year net income and earnings per share, alongside fresh 2026 operating EPS guidance. The company also reaffirmed a US$0.18 per share dividend for March 2026, so you are getting earnings, outlook and income signals at the same time, which can shape how you look at the stock. See our latest analysis for Corteva. Corteva’s...

Recent performance snapshot Sila Realty Trust (SILA) has drawn investor attention after a recent stretch of positive returns, with the stock showing gains over the past week, month and past 3 months, alongside an annual revenue figure of US$193.381 million. See our latest analysis for Sila Realty Trust. At a share price of US$25.16, Sila Realty Trust has recently logged a 7.89% 1 month share price return and a 7.06% year to date share price return. The 1 year total shareholder return of 7.28%...

Federal funding spotlight and upcoming milestones MP Materials (MP) is back in focus after Washington moved to commit large federal funding for critical mineral reserves, with the company viewed as a likely key supplier in this program. This policy backdrop, combined with MP Materials' upcoming processing plant and the planned fourth quarter 2025 results update, has drawn fresh attention to how the stock reflects its role in rare earth supply chains. See our latest analysis for MP...

The U.S. Department of Justice is reportedly weighing an antitrust investigation into large homebuilders, including D.R. Horton (NYSE:DHI). The potential probe is expected to focus on competition practices across major construction firms. The development raises fresh regulatory questions for one of the largest publicly traded homebuilders in the United States. D.R. Horton, listed on the NYSE under the ticker DHI, is a major player in U.S. residential construction, with exposure across...

In January 2026, Halozyme Therapeutics raised its 2026 total revenue guidance to a range of US$1.71 billion to US$1.81 billion, up from its prior outlook of US$1.43 billion to US$1.53 billion, and also projected 2025 revenue of about US$1.39 billion with mid‑thirties percentage year-on-year growth. This guidance update highlights how demand for Halozyme’s ENHANZE-enabled subcutaneous delivery partnerships is feeding through into higher expected top-line scale and cash generation. Next, we’ll...

Federal judge upholds Zillow Group's listing policy in Compass litigation. Ruling affirms Zillow's ban on private home listings on its platform. Decision arrives as exclusive and private listings face increased industry scrutiny. Case unfolds against the backdrop of Compass's merger with Anywhere. Zillow Group, traded as NasdaqGS:ZG, runs one of the most widely used online real estate platforms, connecting homebuyers, sellers, renters, and agents. The court's backing of its policy against...

Amazon plans about $200b in capital expenditure in 2026, with a significant focus on AI infrastructure. Marvell Technology (NasdaqGS:MRVL) supplies custom AI processors that could be used in this build out. Marvell is also involved in Project Rainier for Anthropic, tying its technology into Amazon linked AI workloads. Marvell Technology, trading at $82.35, sits at the intersection of custom AI chips and cloud data infrastructure, which is an area where Amazon is ramping up spend. The stock...

On February 5, 2026, WD-40 Co Director David Pendarvis bought 424 company shares, lifting his total holding to 6,898, according to an SEC filing. This purchase extends a year-long pattern of insider buying at WD-40 Co, with no insider sales reported, highlighting sustained internal confidence. Next, we’ll assess how this ongoing insider buying trend shapes WD-40 Co’s investment narrative and what it might signal to investors. We've uncovered the 14 dividend fortresses yielding 5%+ that don't...

Omnicom Group (OMC) has drawn fresh attention after filing a shelf registration for up to US$2.14 billion of common stock, related to an employee stock ownership plan offering of 27,390,000 shares. See our latest analysis for Omnicom Group. At a share price of US$70.75, Omnicom Group has recently seen pressure, with a 7 day share price return of 7.54% and a 30 day share price return of 10.53%, while the 1 year total shareholder return of 11.11% and 3 year total shareholder return of 15.95%...

HP (HPQ) is back in focus after Enrique Lores stepped down as CEO and President, and board member Bruce Broussard became Interim CEO as the company starts a formal search for a permanent leader. See our latest analysis for HP. At a share price of US$19.43, HP has seen a 22.93% decline in its 90 day share price return and a 38.79% drop in its 1 year total shareholder return. This suggests momentum has been fading even as the company reaffirmed 2026 earnings guidance, updated its bylaws and...

Recent performance snapshot Without a single headline event setting the tone, Principal Financial Group (PFG) has still given investors a fair amount to think about, with the shares recently closing at $95.93. The stock shows a 1 day return of a 1.45% decline, while the past week is slightly positive at 0.67%. Over the past month and past 3 months, returns of 6.25% and 12.51% highlight a different picture from the near term move. See our latest analysis for Principal Financial Group. That...

If you are wondering whether Harley-Davidson is quietly turning into a value story, the stock's recent performance gives you a starting point but not the full picture. The share price closed at US$20.14, with a 3.0% gain over the last 7 days, while the 30 day, year to date and 1 year returns of 6.0% decline, 2.4% decline and 19.6% decline show a tougher run over longer periods. Recent coverage has focused on Harley-Davidson's position as a long established motorcycle brand and how sentiment...

Becton Dickinson (NYSE:BDX) has completed a $17.5b spin off and merger of its Biosciences and Diagnostic Solutions businesses with Waters. The deal restructures Becton Dickinson as a more focused medtech company and is paired with a new capital allocation plan. The company reported strong Q1 results alongside the announcement of a $2b share repurchase program and debt reduction plans. Becton Dickinson, trading around $207.39, is reshaping itself around its core medtech operations after this...

Q1 earnings put Atkore’s recent performance in focus Atkore (ATKR) has come under closer scrutiny after first quarter results showed sales of US$655.55 million versus US$661.6 million a year earlier, with net income at US$15.03 million compared with US$46.34 million. See our latest analysis for Atkore. The weaker first quarter result comes after a period where short-term share price momentum has faded, with a 7-day share price return showing a decline of 4.81% and a 1-year total shareholder...

Amneal Pharmaceuticals, Inc. was recently added to the S&P 1000, S&P Composite 1500, S&P 600, and S&P 600 Health Care indices, while also making effective on January 29, 2026, a nationwide opioid settlement that includes US$88.5 million in cash payments and up to US$177.4 million in naloxone nasal spray over ten years. This combination of index inclusions and a broad opioid settlement materially reshapes Amneal’s profile by widening its investor base and reducing legal uncertainty with...

Snowflake (NYSE:SNOW) announced a multi-year partnership with OpenAI to bring models such as GPT-5.2 directly into its Cortex AI platform. The collaboration focuses on co-developing enterprise AI tools, including custom AI agents, with built-in governance and security controls. Snowflake also introduced new AI driven products like Cortex Code and Semantic View Autopilot, plus new industry offerings, including Energy Solutions. Snowflake is trading at $175.95, with returns of 8.6% over 3...